[go: up one dir, main page]

ZA99686B - Treatment of female sexual dysfunction. - Google Patents

Treatment of female sexual dysfunction.

Info

Publication number
ZA99686B
ZA99686B ZA9900686A ZA99686A ZA99686B ZA 99686 B ZA99686 B ZA 99686B ZA 9900686 A ZA9900686 A ZA 9900686A ZA 99686 A ZA99686 A ZA 99686A ZA 99686 B ZA99686 B ZA 99686B
Authority
ZA
South Africa
Prior art keywords
treatment
sexual dysfunction
female sexual
female
dysfunction
Prior art date
Application number
ZA9900686A
Other languages
English (en)
Inventor
Ragab El-Rashidy
Bruce Ronsen
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Publication of ZA99686B publication Critical patent/ZA99686B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9900686A 1998-01-30 1999-01-28 Treatment of female sexual dysfunction. ZA99686B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/016,252 US5945117A (en) 1998-01-30 1998-01-30 Treatment of female sexual dysfunction

Publications (1)

Publication Number Publication Date
ZA99686B true ZA99686B (en) 1999-07-28

Family

ID=21776169

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900686A ZA99686B (en) 1998-01-30 1999-01-28 Treatment of female sexual dysfunction.

Country Status (34)

Country Link
US (2) US5945117A (fr)
EP (1) EP1056419A4 (fr)
JP (1) JP2002501875A (fr)
KR (1) KR20010040477A (fr)
CN (1) CN1250221C (fr)
AR (1) AR017976A1 (fr)
AU (1) AU752928B2 (fr)
BG (1) BG64667B1 (fr)
BR (1) BR9908038A (fr)
CA (1) CA2322289A1 (fr)
CO (1) CO4970819A1 (fr)
CR (1) CR5959A (fr)
DZ (1) DZ2714A1 (fr)
GC (1) GC0000096A (fr)
GT (1) GT199900013A (fr)
HK (1) HK1040901B (fr)
HN (1) HN1999000015A (fr)
HU (1) HUP0101268A3 (fr)
IL (2) IL137569A0 (fr)
JO (1) JO2085B1 (fr)
MA (1) MA26600A1 (fr)
MX (1) MXPA00007447A (fr)
NO (1) NO319821B1 (fr)
NZ (1) NZ506597A (fr)
PA (1) PA8467801A1 (fr)
PE (1) PE20000240A1 (fr)
PL (1) PL194350B1 (fr)
SK (1) SK11362000A3 (fr)
TN (1) TNSN99008A1 (fr)
TR (1) TR200002220T2 (fr)
TW (1) TW550069B (fr)
UY (1) UY25374A1 (fr)
WO (1) WO1999038467A1 (fr)
ZA (1) ZA99686B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165122A1 (en) * 1994-04-22 2002-11-07 Heaton Jeremy P. W. Method and compositions for the treatment or amelioration of female sexual dysfunction
US6395744B1 (en) * 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
AU2003204720B2 (en) * 1998-05-29 2006-06-29 Tap Pharmaceutical Products Inc. Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
AU4254799A (en) * 1998-06-22 2000-01-10 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050245494A1 (en) * 1999-07-01 2005-11-03 40 J's Llc Methods to treat one or all of the defined etiologies of female sexual dysfunction
US20050020547A1 (en) * 1999-11-08 2005-01-27 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
BR0005797A (pt) * 2000-03-20 2001-10-16 Abbott Lab Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
HUP0301773A3 (en) 2000-04-07 2006-02-28 Tap Pharmaceutical Prod Inc Apomorphine derivatives and methods for their use
CA2408399A1 (fr) * 2000-05-09 2001-11-15 Nitromed, Inc. Thermographie infrarouge et procede d'utilisation d'applications associees
ES2291333T3 (es) 2000-06-27 2008-03-01 Qualilife Pharmaceuticals Inc. Composiciones y metodos para el tratamiento de la respuesta sexual de las mujeres.
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
EP1365794A2 (fr) * 2000-07-21 2003-12-03 Lue, Tom Methodes et compositions destinees a prevenir et traiter la dyserection chez l'homme et les troubles de l'excitation sexuelle chez la femme
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
EP1341536A4 (fr) 2000-11-15 2007-08-01 Tap Pharmaceutical Prod Inc Traitement d'un dysfonctionnement sexuel entraine par une medication antidepressive par apomorphine
ES2284727T3 (es) * 2000-11-22 2007-11-16 Abbott Laboratories Agonistas selectivos del receptor de dopamina d4 para tratar disfuncion sexual.
US20030022912A1 (en) * 2001-02-08 2003-01-30 Martino Alice C. Rapid-onset medicament for treatment of sexual dysfunction
BR0308567A (pt) * 2002-03-19 2007-01-09 Michael Holick derivados de glicosìdeo e glicosìdeo de ortoéster de apomorfina, análogos, e seus usos
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
GB0221711D0 (en) * 2002-09-19 2002-10-30 Ardana Bioscience Ltd Methods
US20040138291A1 (en) * 2002-10-10 2004-07-15 Adams Michael A. Treatment of sexual dysfunction
CA2451267A1 (fr) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Utilisations pharmaceutiques de ligands alpha2delta
AU2004228757A1 (en) * 2003-04-14 2004-10-21 Vectura Ltd Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
CA2564994A1 (fr) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Composes de morpholine substitues permettant de traiter des troubles du systeme nerveux central
CA2602383A1 (fr) * 2005-03-21 2006-09-28 Pfizer Limited Derives de triazole substitues utilises en tant qu'antagonistes d'oxytocine
CA2602198C (fr) * 2005-03-21 2010-11-09 Pfizer Limited Derives de triazole substitues en tant qu'antagonistes d'oxytocine
WO2006105615A1 (fr) * 2005-04-08 2006-10-12 Ozpharma Pty Ltd Procede d’administration orale
WO2007017752A1 (fr) * 2005-08-10 2007-02-15 Pfizer Limited Derives de triazole substitues en tant qu'antagonistes d'oxytocine
EP2233472B1 (fr) 2006-03-28 2014-01-15 Atir Holding S.A. Composés hétérocycliques et leurs utilisations dans le traitement de troubles sexuels
US7800094B2 (en) * 2007-06-11 2010-09-21 Macronix International Co., Ltd. Resistance memory with tungsten compound and manufacturing
US9044475B2 (en) 2009-06-12 2015-06-02 Cynapsus Therapeutics, Inc. Sublingual apomorphine
US20130210867A1 (en) * 2010-04-15 2013-08-15 Life Science Enhancement Corporation Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
WO2012083269A1 (fr) 2010-12-16 2012-06-21 Cynapsus Therapeutics, Inc. Films sublinguaux
WO2012140642A1 (fr) 2011-04-10 2012-10-18 Atir Holding S.A. Composés hétérocycliques et leurs utilisations dans le traitement de troubles sexuels
EP2545905A1 (fr) 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited Nouvelle composition thérapeutique contenant de l'apomorphine en tant que principe actif
JP7211706B2 (ja) 2015-04-21 2023-01-24 サノヴィオン ファーマシュティカルズ インコーポレーテッド 口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
EP0641202A1 (fr) * 1992-05-18 1995-03-08 Smithkline Beecham Plc Emploi de derives d'indolone dans le traitement de troubles de la memoire, du dysfonctionnement sexuel et de la maladie de parkinson
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
DE10199068I2 (de) * 1994-04-22 2004-05-06 Pentech Pharmaceuticals Inc Sublinguale Dosierungsformen enthaltend apomorphinzur Verwendung bei der Behandlung von erektiler D ysfunktion.
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction

Also Published As

Publication number Publication date
JO2085B1 (en) 2000-05-21
CR5959A (es) 1999-07-28
US6193992B1 (en) 2001-02-27
NO20003845D0 (no) 2000-07-27
SK11362000A3 (sk) 2001-02-12
HK1040901A1 (en) 2002-06-28
TW550069B (en) 2003-09-01
IL137569A0 (en) 2001-07-24
US5945117A (en) 1999-08-31
BG64667B1 (bg) 2005-11-30
GC0000096A (en) 2005-06-29
WO1999038467A1 (fr) 1999-08-05
DZ2714A1 (fr) 2003-09-01
CO4970819A1 (es) 2000-11-07
EP1056419A4 (fr) 2007-05-02
HUP0101268A3 (en) 2002-12-28
TR200002220T2 (tr) 2000-12-21
BG104715A (bg) 2001-02-28
NO319821B1 (no) 2005-09-19
AU2564499A (en) 1999-08-16
MA26600A1 (fr) 2004-12-20
HN1999000015A (es) 1999-08-23
AR017976A1 (es) 2001-10-24
BR9908038A (pt) 2002-01-02
CN1250221C (zh) 2006-04-12
NZ506597A (en) 2003-07-25
PA8467801A1 (es) 2000-09-29
UY25374A1 (es) 1999-09-27
MXPA00007447A (es) 2006-01-25
TNSN99008A1 (fr) 2005-11-10
JP2002501875A (ja) 2002-01-22
HUP0101268A2 (hu) 2001-09-28
PL342062A1 (en) 2001-05-21
CN1313742A (zh) 2001-09-19
EP1056419A1 (fr) 2000-12-06
PE20000240A1 (es) 2000-03-31
HK1040901B (zh) 2006-11-24
KR20010040477A (ko) 2001-05-15
NO20003845L (no) 2000-09-28
AU752928B2 (en) 2002-10-03
PL194350B1 (pl) 2007-05-31
GT199900013A (es) 2001-07-20
CA2322289A1 (fr) 1999-08-05
IL137569A (en) 2006-08-01

Similar Documents

Publication Publication Date Title
GC0000096A (en) Treatment of female sexual dysfunction.
EP1027057A4 (fr) Traitement du dysfonctionnement sexuel chez la femme
IL153492A0 (en) Treatment of male sexual dysfunction
IL141553A0 (en) Drug preparations for treating sexual dysfunction
GB9608408D0 (en) Treatment of erectile dysfunction
GB0225908D0 (en) Treatment of female sexual dysfunction
AU3894600A (en) Method of treating sexual dysfunction
AU3776799A (en) Methods for treating female sexual dysfunction
IL155775A0 (en) Treatment of male sexual dysfunction
EP1079764A4 (fr) Traitement des troubles de la sexualite chez certains groupes de patients
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
PL362980A1 (en) Treatment of sexual dysfunction
GB2386555B (en) Treatment of female sexual dysfunction
ZA200006378B (en) Compounds for the treatment of female sexual dysfunction.
GB0030647D0 (en) Treatment of male sexual dysfunction
SI1047428T1 (sl) Uporaba morfolinola za zdravljenje seksualne disfunkcije
GB0011926D0 (en) Treatment of sexual dysfunction
ZA994585B (en) Treatment of water.
GB9928178D0 (en) Agent for the treatment of male and female sexual dysfunction
GB0108730D0 (en) Treatment of male sexual dysfunction
GB0106167D0 (en) Treatment of male sexual dysfunction
GB0108483D0 (en) Treatment of male sexual dysfunction
GB0120679D0 (en) Treatment of male sexual dysfunction
GB9813291D0 (en) Sexual dysfunction